Global Gene Editing Market Size Likely to Grow at a CAGR of 25.81% By 2034

Global Gene Editing Market size was valued at USD 5.65 Billion in 2025. It is expected to reach USD 29.28 Billion in 2034, growing at a CAGR of 25.81% over the forecast period 2025 – 2034.

Gene Editing Market: Growth Factors and Dynamics

The gene editing market will experience growth during the forecast period due to the increasing funding for genetic research in developed regions, such as North America. In the United States, over 20 federal agencies funded research and development government firms to develop practical materials, devices, and methodologies.

Additionally, the U.S. government’s funding of numerous research firms facilitates the development and manufacturing of drugs for various rare genetic maladies. For example, the National Human Genome Research Institute supports research programs and projects that aim to advance the field of genomics.

In the same vein, the National Institutes of Health (NIH), a component of the U.S. government’s Health and Human Services and the nation’s medical research agency, is accountable for research activities in biomedical and genetics.

In 2021, the National Institutes of Health (NIH) provided approximately USD 1.6 million to the Arizona State University and Bayer College of Medicine to assess recent developments in human genome editing. The mortality rate has been reduced by the recently developed drugs that are specifically designed to treat genetic disorders. This development is anticipated to stimulate the growth of the gene editing market in the future.

The pharmaceutical industry’s demand for targeted treatments for various diseases and the food industry’s demand for superior products with enhanced quality and nutrient enrichment are the primary factors contributing to the growth.

The global CRISPR gene editing market is driven by the continued substantial investments by healthcare providers to satisfy the industry demand and the increasing prominence of gene therapy procedures with a shorter turnaround time.

Institutes, pharmaceutical and biotechnology industries, and research organizations are seeking genome editing technologies that are more efficient in reducing human errors and turnover time, as well as in increasing specificity and cost-effectiveness.

Additionally, the development of genome editing technologies has facilitated the investigation of various applications in industries such as biotechnology, agriculture, and industrial research. These sophisticated techniques are cost-effective, uncomplicated, and highly efficient, offering high throughput and multiplexing capabilities.

The CRISPR gene editing market is anticipated to experience a substantial increase in demand due to the growing global geriatric population and the concurrent rise in the number of cancer cases and genetic disorders.

Additionally, organizations are allocating substantial resources to research and develop gene therapies and CRISPR gene editing products. In recent years, there has been an increase in the number of clinical trials for various genetic and chronic diseases. This will contribute to the future expansion of the CRISPR gene editing market.

Report Scope

Gene Editing Market: Recent Developments

• In June 2021, Allele Biotechnology and Alpine BioTherapeutics Corporation announced an agreement to collaborate on developing induced pluripotent stem cells to treat retinal diseases. This strategy facilitated the company’s development of a sophisticated product portfolio.

• MaxCyte and Caribou Science executed a commercial and clinical license agreement in May 2020. The agreement aimed to secure exclusive rights to utilize the ExPERT platform and MaxCyte’s flow electroporation technology. This approach facilitated the advancement of Caribou’s gene-edited allogeneic T-cell therapy programs and the expansion of their corporate relationships in the gene editing market.

Gene Editing Market: Trends

• Increased investments in biotechnology and healthcare have facilitated the development and commercialization of genome editing technologies. By providing funding, researchers can conduct clinical trials, conduct studies, and develop medical solutions based on laboratory findings.

• One of the most significant contributions of genome editing to personalized medicine is the customization of treatments to the unique genetic composition of each individual. This method has the potential to reduce adverse effects and improve treatment efficacy.

• Agricultural genetic engineering is being implemented to cultivate more nutritious crops resistant to pests and diseases and yield higher yields. This application has the potential to enhance sustainable agriculture and food security.

List of the prominent players in the Gene Editing Market:

• CRISPR Therapeutics AG
• Thermo Fisher Scientific Inc.
• Synthego Corporation
• System Biosciences LLC
• ToolGen Inc.
• Agilent Technologies Inc.
• Rockland Immunochemicals Inc.
• GeneCopoeia Inc.
• Horizon Discovery Group PLC
• Abcam Inc.
• Applied StemCell Inc.
• Cellecta Inc.
• Integrated DNA Technologies Inc.
• Merck KGaA
• New England Biolabs Inc.
• Others

The Gene Editing Market is segmented as follows:

By Product Type

• CRISPR Products
  • Kits and Enzymes
  • Libraries
  • Design Tools, Antibodies
  • Others
• CRISPR Services
  • gRNA Design and Vector Construction
  • Cell Line and Engineering
  • Screening Services
  • Others

By Application

• Agricultural
• Biomedical
• Industrial
• Genome Engineering
• Disease Models
• Functional Genomics
• Others

By End User

• Academic Institutes and Research Centres
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Pharmaceutical and Biopharmaceutical Companies

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America